Scienture Holdings Inc
SCNX0.571USD
+0.072+14.47%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
13.20MMarket Cap
LossP/E TTM
More Details of Scienture Holdings Inc Company
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
Scienture Holdings Inc Info
Ticker SymbolSCNX
Company nameScienture Holdings Inc
IPO dateFeb 18, 2020
CEOHariharan (Shankar)
Number of employees14
Security typeOrdinary Share
Fiscal year-endFeb 18
Address- -
City- -
Stock exchangeNASDAQ OMX - NASDAQ BASIC
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolSCNX
IPO dateFeb 18, 2020
CEOHariharan (Shankar)
Company Executives of Scienture Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
2.45M
+72.77%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
50.00K
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
2.45M
+72.77%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
50.00K
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025Q2
FY2025Q1
FY2024
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Nov 27
Updated: Thu, Nov 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hariharan (Shankar Ph.D.)
8.34%
Mani (Narasimhan)
6.02%
Doshi (Mayur Mansukhlal)
1.05%
Fell (Donald G.)
0.80%
Jayanthi (Subbarao)
0.49%
Other
83.29%
Shareholders
Shareholders
Proportion
Hariharan (Shankar Ph.D.)
8.34%
Mani (Narasimhan)
6.02%
Doshi (Mayur Mansukhlal)
1.05%
Fell (Donald G.)
0.80%
Jayanthi (Subbarao)
0.49%
Other
83.29%
Shareholder Types
Shareholders
Proportion
Individual Investor
16.83%
Investment Advisor
0.81%
Hedge Fund
0.42%
Investment Advisor/Hedge Fund
0.24%
Other
81.70%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
22
464.78K
6.50%
+241.53K
2025Q2
28
4.45M
32.07%
+469.00
2025Q1
32
4.45M
33.93%
+9.47K
2024Q4
36
4.62M
68.10%
+3.89M
2024Q3
36
1.01M
65.38%
+269.18K
2024Q2
37
1.00M
67.44%
+530.62K
2024Q1
34
476.38K
36.25%
+95.67K
2023Q4
35
386.59K
47.32%
+20.29K
2023Q3
38
376.26K
55.40%
-6.85K
2023Q2
38
402.57K
59.37%
+44.99K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hariharan (Shankar Ph.D.)
2.37M
11.22%
--
--
Jan 27, 2025
Mani (Narasimhan)
1.42M
6.7%
--
--
Jan 27, 2025
Doshi (Mayur Mansukhlal)
66.45K
0.31%
--
--
Jan 27, 2025
Fell (Donald G.)
35.16K
0.17%
--
--
Jan 27, 2025
The Vanguard Group, Inc.
14.57K
0.07%
--
--
Jun 30, 2025
Scoggin Management LP
150.00K
0.71%
+150.00K
--
Aug 14, 2025
Geode Capital Management, L.L.C.
28.68K
0.14%
-3.48K
-10.83%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Date
Type
Ratio
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
FAQs
Who are the top five shareholders of Scienture Holdings Inc?
The top five shareholders of Scienture Holdings Inc are:
Hariharan (Shankar Ph.D.) holds 2.37M shares, accounting for 11.22% of the total shares.
Mani (Narasimhan) holds 1.42M shares, accounting for 6.70% of the total shares.
Doshi (Mayur Mansukhlal) holds 66.45K shares, accounting for 0.31% of the total shares.
Fell (Donald G.) holds 35.16K shares, accounting for 0.17% of the total shares.
The Vanguard Group, Inc. holds 14.57K shares, accounting for 0.07% of the total shares.
Hariharan (Shankar Ph.D.) holds 2.37M shares, accounting for 11.22% of the total shares.
Mani (Narasimhan) holds 1.42M shares, accounting for 6.70% of the total shares.
Doshi (Mayur Mansukhlal) holds 66.45K shares, accounting for 0.31% of the total shares.
Fell (Donald G.) holds 35.16K shares, accounting for 0.17% of the total shares.
The Vanguard Group, Inc. holds 14.57K shares, accounting for 0.07% of the total shares.
What are the top three shareholder types of Scienture Holdings Inc?
The top three shareholder types of Scienture Holdings Inc are:
Hariharan (Shankar Ph.D.)
Mani (Narasimhan)
Doshi (Mayur Mansukhlal)
Hariharan (Shankar Ph.D.)
Mani (Narasimhan)
Doshi (Mayur Mansukhlal)
How many institutions hold shares of Scienture Holdings Inc (SCNX)?
As of 2025Q3, 22 institutions hold shares of Scienture Holdings Inc, with a combined market value of approximately 464.78K, accounting for 6.50% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -25.56%.
What is the biggest source of revenue for Scienture Holdings Inc?
In FY2025Q2, the -- business generated the highest revenue for Scienture Holdings Inc, amounting to -- and accounting for --% of total revenue.
